Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial-Reference-Cited by-同舟云学术

Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial

Published:2018-10-19 Issue:1 Volume:18 Page:
ISSN:1471-2261
Container-title:BMC Cardiovascular Disorders
language:en
Short-container-title:BMC Cardiovasc Disord

Author:

Le Corvoisier Philippe^ORCID,Gallet Romain,Lesault Pierre-François,Audureau Etienne,Paul Muriel,Ternacle Julien,Ghostine Saïd,Champagne Stéphane,Arrouasse Raphaele,Bitari Dalila,Mouillet Gauthier,Dubois-Randé Jean-Luc,Berdeaux Alain,Ghaleh Bijan,Deux Jean-François,Teiger Emmanuel

Funder

Société Française de Cardiologie

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12872-018-0936-8.pdf

Reference30 articles.

1. Smolina K, Wright FL, Rayner M, Goldacre MJ. Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ. 2012;344:d8059.

2. Sulo G, Igland J, Vollset SE, Nygard O, Ebbing M, Sulo E, et al. Heart failure complicating acute myocardial infarction: burden and timing of occurrence. J Am Heart Assoc. 2016;5:1-8.

3. Frohlich GM, Meier P, White SK, Yellon DM, Hausenloy DJ. Myocardial reperfusion injury: looking beyond primary PCI. Eur Heart J. 2013;34:1714–22.